SCHEMBL20053748

SCHEMBL20053748

CCCC[C@H]1C(=O)N(C)[C@@H](CCCC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)NCC(N)=O)CSCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N(C)[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N2CCC[C@H]2C(=O)N[C@@H](CN)C(=O)NC(C)(C)C(=O)N2CCC[C@H]2C(=O)N[C@@H](Cc2c[nH]c3ccccc23)C(=O)N[C@@H](CCN)C(=O)N[C@@H](Cc2c[nH]c3ccccc23)C(=O)N1C

nearest known ligand 0.72

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
CD274 Q9NZQ7 9/20 0.72
PDCD1 Q15116 7/20 0.67
CIB1 Q99828 5/20 0.58
ROR1 Q01973 1/20 0.49
KLKB1 P03952 3/20 0.48
PCSK9 Q8NBP7 2/20 0.45
LDLR P01130 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20053703 0.97 CD274 (0.68) CD274PDCD1CIB1ROR1KLKB1
SCHEMBL17854755 0.96 CD274 (0.68) CD274PDCD1CIB1ROR1KLKB1
SCHEMBL16128641 0.96 CD274 (0.74) CD274PDCD1CIB1ROR1KLKB1
SCHEMBL16128548 0.96 CD274 (0.74) CD274PDCD1CIB1ROR1KLKB1
SCHEMBL19340577 0.96 CD274 (0.74) CD274PDCD1CIB1ROR1KLKB1
SCHEMBL20053640 0.96 CD274 (0.71) CD274PDCD1CIB1ROR1KLKB1
SCHEMBL20053642 0.95 CD274 (0.69) CD274PDCD1CIB1ROR1KLKB1
SCHEMBL20053687 0.93 CD274 (0.64) CD274PDCD1CIB1ROR1KLKB1
SCHEMBL17854758 0.93 CD274 (0.64) CD274PDCD1CIB1ROR1KLKB1
SCHEMBL20053745 0.93 CD274 (0.71) CD274PDCD1CIB1ROR1KLKB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9944678-B2 Immunomodulators BRISTOL-MYERS SQUIBB COMPANY (US) 2018-04-17 US disclosed